Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

SEER

Seer Inc

Jun 18 • 04:00PM ET

1.67

Dollar change -0.05
Percentage change -2.91	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM IWN VXF PRFZ VTWO SCHA VHT IWC AVSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.29	Insider Own	25.37%	Shs Outstand	60.25M	Perf Week	-7.73%
Market Cap	108.45M	Forward P/E	-	EPS next Y	-1.30	Insider Trans	-0.57%	Shs Float	48.46M	Perf Month	-20.85%
Income	-83.00M	PEG	-	EPS next Q	-0.36	Inst Own	50.70%	Short Float	5.71%	Perf Quarter	-13.02%
Sales	15.42M	P/S	7.03	EPS this Y	5.19%	Inst Trans	-1.93%	Short Ratio	6.08	Perf Half Y	-4.57%
Book/sh	5.91	P/B	0.28	EPS next Y	-1.56%	ROA	-18.55%	Short Interest	2.77M	Perf Year	-62.30%
Cash/sh	4.75	P/C	0.35	EPS next 5Y	-11.70%	ROE	-20.33%	52W Range	1.46 - 5.65	Perf YTD	-13.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-67.17%	ROI	-20.29%	52W High	-70.44%	Beta	1.46
Dividend TTM	-	Quick Ratio	24.81	Sales past 5Y	294.65%	Gross Margin	10.45%	52W Low	14.78%	ATR (14)	0.09
Dividend Ex-Date	-	Current Ratio	25.27	EPS Y/Y TTM	12.80%	Oper. Margin	-658.20%	RSI (14)	34.04	Volatility	4.61% 4.78%
Employees	147	Debt/Eq	0.07	Sales Y/Y TTM	-0.47%	Profit Margin	-538.38%	Recom	2.33	Target Price	7.00
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	15.07%	Payout	-	Rel Volume	0.80	Prev Close	1.72
Sales Surprise	-18.42%	EPS Surprise	-6.67%	Sales Q/Q	-24.35%	Earnings	May 08 AMC	Avg Volume	455.19K	Price	1.67
SMA20	-9.78%	SMA50	-12.29%	SMA200	-11.44%	Trades		Volume	362,591	Change	-2.91%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Neutral	$10
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform	$9 → $6.50
Aug-11-22	Downgrade	JP Morgan	Overweight → Neutral	$20 → $12
Oct-15-21	Resumed	Cowen	Outperform
Dec-29-20	Initiated	Morgan Stanley	Equal-Weight	$65
Dec-29-20	Initiated	JP Morgan	Overweight	$75
Dec-29-20	Initiated	Cowen	Outperform
Dec-29-20	Initiated	BofA Securities	Neutral	$69

Jun-11-24 11:11AM	Seer Proteograph Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery (GlobeNewswire)
Jun-02-24 10:55AM	Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study (GlobeNewswire)
May-10-24 03:51PM	Seer Inc (SEER) Q1 2024 Earnings: Revenue Declines but Losses Narrow, Meeting Some Analyst ... (GuruFocus.com)
May-09-24 02:38PM	Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.62%
07:11AM	Q1 2024 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
03:49AM	Seer Inc (SEER) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 09:57PM	SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:45PM	Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions (GlobeNewswire)
Apr-23-24 04:05PM	Seer to Report First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire) +8.38%
Mar-02-24 08:18AM	Seer, Inc. (NASDAQ:SEER) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 07:23AM	Q4 2023 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-29-24 06:00PM	Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:39PM	Seer Inc (SEER) Reports Mixed Financial Results for Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook (GlobeNewswire)
Feb-21-24 04:05PM	Seer to Participate in the TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-06-24 08:00AM	Seer Proteograph Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery (GlobeNewswire) +5.99%
Feb-02-24 09:55AM	Here's Why Seer, Inc. (SEER) Could be Great Choice for a Bottom Fisher (Zacks)
Feb-01-24 04:05PM	Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (GlobeNewswire)
Dec-21-23 04:05PM	Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference (GlobeNewswire)
Nov-10-23 09:00AM	Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-08-23 02:34PM	Seer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.23%
09:00AM	Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 (GlobeNewswire)
Nov-07-23 07:25PM	Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:07PM	Seer Inc (SEER) Reports Modest Revenue Growth Amidst Economic Headwinds (GuruFocus.com)
04:05PM	Seer Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-01-23 09:00AM	Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program (GlobeNewswire)
Oct-19-23 04:05PM	Seer to Report Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire)
Sep-28-23 08:10PM	7 Contrarian Stocks to Buy for the High-Stakes Gambler (InvestorPlace)
Sep-08-23 04:05PM	Seer to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-09-23 03:12PM	Why Shares of Seer Are Slumping Wednesday (Motley Fool) -33.69%
Aug-08-23 08:05PM	Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Seer Reports Second Quarter 2023 Financial Results (GlobeNewswire)
08:28AM	We Think Seer (NASDAQ:SEER) Can Afford To Drive Business Growth (Simply Wall St.)
Jul-27-23 04:05PM	Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-13-23 04:05PM	Seer to Report Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire) -7.54%
Jun-07-23 09:00AM	Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center (GlobeNewswire)
Jun-01-23 09:00AM	Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies (GlobeNewswire) +7.07%
May-09-23 06:15PM	Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-24-23 08:56AM	Seer (NASDAQ:SEER) investors are sitting on a loss of 57% if they invested a year ago (Simply Wall St.)
Apr-20-23 04:05PM	Seer to Report First Quarter 2023 Financial Results on May 9, 2023 (GlobeNewswire) -5.40%
Mar-29-23 02:00PM	Seers Proteograph Product Suite identifies undiscovered links between protein variants and lung cancer progression (GlobeNewswire)
Mar-28-23 08:23AM	With 54% ownership of the shares, Seer, Inc. (NASDAQ:SEER) is heavily dominated by institutional owners (Simply Wall St.)
Mar-03-23 08:52AM	Q4 2022 Seer Inc Earnings Call (Thomson Reuters StreetEvents) +29.45%
Mar-02-23 05:35PM	Seer, Inc. (SEER) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +7.67%
04:05PM	Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook (GlobeNewswire)
Mar-01-23 06:15AM	Companies Like Seer (NASDAQ:SEER) Are In A Position To Invest In Growth (Simply Wall St.)
Feb-27-23 09:35AM	Down -26.63% in 4 Weeks, Here's Why You Should You Buy the Dip in Seer, Inc. (SEER) (Zacks) +5.11%
Feb-23-23 12:00PM	Seer, Inc. (SEER) Moves to Buy: Rationale Behind the Upgrade (Zacks)
10:00AM	Seer, Inc. (SEER) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-21-23 04:30PM	Seer to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire) -11.26%
Feb-09-23 04:05PM	Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 (GlobeNewswire)
Dec-27-22 04:05PM	Seer to Present at the J.P. Morgan 41st Annual Health Care Conference (GlobeNewswire) -10.27%
Dec-14-22 08:00AM	DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS (PR Newswire)
Dec-12-22 10:00AM	Seers Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist (GlobeNewswire)
Nov-16-22 05:36AM	Analysts Just Made A Major Revision To Their Seer, Inc. (NASDAQ:SEER) Revenue Forecasts (Simply Wall St.) -9.14%
Nov-10-22 05:51AM	Seer Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.) +20.32%
Nov-08-22 07:25PM	Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -8.53% +5.60%
04:05PM	Seer Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-02-22 07:29AM	The past year for Seer (NASDAQ:SEER) investors has not been profitable (Simply Wall St.)
Oct-13-22 04:15PM	Seer to Report Third Quarter 2022 Financial Results on November 8, 2022 (GlobeNewswire) -5.75%
Sep-22-22 06:43AM	We Think Seer (NASDAQ:SEER) Can Afford To Drive Business Growth (Simply Wall St.)
Aug-30-22 04:05PM	Seer to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire) +8.72%
Aug-23-22 08:00AM	Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome (GlobeNewswire)
Aug-12-22 06:22AM	Analysts Have Been Trimming Their Seer, Inc. (NASDAQ:SEER) Price Target After Its Latest Report (Simply Wall St.) +11.41%
Aug-10-22 06:30PM	Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript (Motley Fool) +29.60% -19.68%
Aug-09-22 07:25PM	Seer, Inc. (SEER) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.81%
04:05PM	Seer Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-03-22 09:00AM	Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph Analysis Suite 2.0 (GlobeNewswire) +13.42%
Jul-14-22 04:05PM	Seer to Report Second Quarter 2022 Financial Results on August 9, 2022 (GlobeNewswire) -5.89%
Jun-27-22 09:39AM	Seer, Inc. (SEER) Stock Jumps 12.9%: Will It Continue to Soar? (Zacks) -10.59%
May-24-22 08:30AM	Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS) (GlobeNewswire) -6.56%
May-15-22 09:05AM	Seer (NASDAQ:SEER) shareholders have endured a 71% loss from investing in the stock a year ago (Simply Wall St.)
May-04-22 08:30PM	Seer, Inc. (SEER) Q1 2022 Earnings Call Transcript (Motley Fool) +5.98%
06:15PM	Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-28-22 04:05PM	Seer to Present at the BofA Securities 2022 Healthcare Conference (GlobeNewswire) -6.37%
Apr-27-22 03:03PM	Analysts Estimate Seer, Inc. (SEER) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-07-22 04:05PM	Seer to Report First Quarter Financial Results on May 4, 2022 (GlobeNewswire)
Mar-16-22 04:05PM	Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer (GlobeNewswire) +7.91% +10.49%
Mar-14-22 08:00AM	Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of Sciences (GlobeNewswire)
Mar-06-22 06:38AM	Here's Why We're Not Too Worried About Seer's (NASDAQ:SEER) Cash Burn Situation (Simply Wall St.)
Mar-04-22 08:00AM	Omid Farokhzad's latest venture promises to disrupt the field of protein research (American City Business Journals) -5.16%
Mar-01-22 05:00AM	Seer, Inc. (SEER) Q4 2021 Earnings Call Transcript (Motley Fool) -9.99%
Feb-28-22 04:05PM	Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook (GlobeNewswire)
Feb-22-22 04:05PM	Seer to Present at the Cowen 42nd Annual Health Care Conference (GlobeNewswire) -7.33%
Feb-21-22 03:01PM	Seer, Inc. (SEER) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-01-22 04:05PM	Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021 (GlobeNewswire) +10.43%
Jan-10-22 02:58PM	Updated: Seer Announces Broad Commercial Release of the Proteograph Product Suite and Launches Centers of Excellence Program (GlobeNewswire)
09:00AM	Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies (GlobeNewswire)
08:00AM	Seer Announces Broad Commercial Release of the Proteograph Product Suite and Launches Centers of Excellence Program (GlobeNewswire)
Dec-31-21 05:40PM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Seer, Inc. and Encourages Investors with Losses to Contact the Firm (ACCESSWIRE)
Dec-29-21 06:51PM	Investigation Alert: Did You Lose Money on Your Stock? Johnson Fistel, LLP Encourages Investors to Contact the Firm (PR Newswire)
08:05AM	Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-23-21 12:07PM	Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP Encourages Investors to Contact the Firm (PR Newswire)
Dec-20-21 11:00AM	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Seer, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation - SEER (PR Newswire)
07:05AM	Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies (GlobeNewswire)
Dec-15-21 02:38AM	Small Company Growth Portfolio Buys DoubleVerify Holdings Inc, The AZEK Co Inc, Repay Holdings ... (GuruFocus.com)

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nishar Dipchand	Director	Jun 14 '24	Sale	1.78	12,109	21,512	79,457	Jun 18 08:00 PM
Farokhzad Omid	CEO AND CHAIR	Mar 07 '24	Sale	2.03	52,857	107,421	1,436,285	Mar 12 06:30 PM
Kogan Elona	CHIEF LEGAL OFFICER	Feb 22 '24	Sale	1.58	12,684	20,024	273,142	Feb 23 05:32 PM
Horn David R.	PRESIDENT & CFO	Feb 22 '24	Sale	1.58	12,684	20,024	480,511	Feb 23 05:30 PM
Horn David R.	President and CFO	Feb 05 '24	Sale	1.67	3,608	6,015	328,157	Feb 07 09:05 PM
Kogan Elona Esq.	Chief Legal Officer	Dec 04 '23	Sale	1.70	8,182	13,869	162,673	Dec 06 04:43 PM
Farokhzad Omid	CEO, President and Chair	Nov 02 '23	Option Exercise	0.04	151,764	6,071	959,508	Nov 03 04:19 PM
Farokhzad Omid	CEO, President and Chair	Aug 23 '23	Buy	2.45	40,000	97,968	807,744	Aug 24 07:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SEER

Seer Inc

Upgrade your FINVIZ experience